Sleep apnea – a ‘hidden epidemic’ for too long
Sleep apnea has been silently troubling millions of people worldwide. Obstructive sleep apnea (OSA) is one of the most common forms of sleep-disordered breathing (SDB). SDB affects not only patients’ sleep, but their waking lives, health and safety. The risks are multiplied for patients with hypertension, cardiac problems and diabetes.
ApneaLink – identify those who are most at risk
- Easy and accurate
- Comfortable and convenient
- Simple reporting with graphic risk indicators
- Optional oximetry
Which patients need to be screened?
A range of symptoms and comorbidities may accompany SDB.
- Loud irregular snoring
- Pronounced daytime fatigue and drowsiness
- Impaired concentration and irritability
- Diabetes Mellitus Type II
- Erectile dysfunction
Easy for patients to use in the comfort of their own home
- Worn like a belt, around the chest area
- Lightweight, does not disrupt sleep
- Easy to use, attach and detach
Untreated SDB – the consequences
- One out of 20 adults suffer from SDB1.
- A significant percentage remain untreated.
- 9.1% of work-related injuries are attributed to sleep disorders2 and people with untreated sleep apnea are at increased risk of a workplace accident.
- SDB is associated with serious comorbidities such as hypertension, cardiac problems and diabetes.
1. Young T, Peppard P, et al. Epidemiology of OSA. Am J Respir Crit Care Med 2002, 165:1217-35
2. Wake up Australia: the value of healthy sleep. Report by Access Economics Pty Ltd for Sleep Health Australia: 2005